The orotidine-5-monophosphate decarboxylase (OMPDC) gene, encoding the final enzyme of the de novo pyrimidine biosynthesis pathway, was deleted using Toxoplasma gondii KU80 knockouts to develop an avirulent nonreverting pyrimidine auxotroph strain. Additionally, to functionally address the role of the pyrimidine salvage pathway, the uridine phosphorylase (UP) salvage activity was knocked out and a double knockout of UP and OMPDC was also constructed. The nonreverting ⌬OMPDC, ⌬UP, and ⌬OMPDC ⌬UP knockout strains were evaluated for pyrimidine auxotrophy, for attenuation of virulence, and for their ability to elicit potent immunity to reinfection. The ⌬UP knockout strain was replication competent and virulent. In contrast, the ⌬OMPDC and ⌬OMPDC ⌬UP strains were uracil auxotrophs that rapidly lost their viability during pyrimidine starvation. Replication of the ⌬OMPDC strain but not the ⌬OMPDC ⌬UP strain was also partially rescued in vitro with uridine or cytidine supplementation. Compared to their hypervirulent parental type I strain, the ⌬OMPDC and ⌬OMPDC ⌬UP knockout strains exhibited extreme attenuation in murine virulence (ϳ8 logs). Genetic complementation of the ⌬OMPDC strain using a functional OMPDC allele restored normal replication and type I parental strain virulence phenotypes. A single immunization of mice with either the live critically attenuated ⌬OMPDC strain or the ⌬OMPDC ⌬UP knockout strain effectively induced potent protective immunity to lethal challenge infection. The avirulent nonreverting ⌬OMPDC and ⌬OMPDC ⌬UP strains provide new tools for the dissection of the host response to infection and are promising candidates for safe and effective Th1 vaccine platforms that can be easily genetically engineered.
Toxoplasma gondii is an obligate intracellular protozoan parasite that invades and replicates in a wide variety of cell types. Infections are widespread in humans, and while infections in healthy individuals are typically asymptomatic, severe disease can occur in utero or in individuals with severe immune suppression (22, 29, 31) . A chronic infection is established and is characterized by quiescent cysts containing bradyzoites in tissues such as brain, muscle, and eye (42) . Chronic infection can reactivate in AIDS and cause toxoplasmic encephalitis (9, 31) or recurrent ocular toxoplasmosis, recently recognized as a prevalent retinal infection in the United States (23, 27) . Current treatments are poorly tolerated and are ineffective against chronic stages of infection, and there are no vaccines. Targeting of the T. gondii de novo pyrimidine synthesis pathway is one potential approach to developing more-effective vaccination strategies based on live attenuated strains with defined genetic disruptions (14) .
The key uracil phosphoribosyltransferase (UPRT) activity in the pyrimidine salvage pathway can easily be disrupted, and loss of UPRT has no apparent effect on parasite growth in vitro or virulence in vivo (4, 8) . In the absence of any pyrimidine salvage pathway, T. gondii still possesses a complete six-step pathway for the de novo biosynthesis of UMP, the precursor molecule of all essential pyrimidines (1, 14, 34, 38) . Insertional disruption of the first step of the biosynthetic pathway, encoded by the carbamoyl phosphate synthetase II (CPSII) gene, produced a severe uracil auxotrophy exemplified by the cps1-1 strain of T. gondii, which was incapable of de novo pyrimidine synthesis (13, 16) . After invasion of a host cell, the cps1-1 uracil auxotrophic mutant was starved for pyrimidines and ceased to proliferate, since uracil is not readily available for salvage in mammals (12, 13, 32) . The cps1-1 mutant strain also exhibited an extreme attenuation of virulence in both immune-competent and severely immune-deficient homozygous gamma interferon (IFN-␥) knockout mice (13) .
Immunization of mice with the live attenuated type I cps1-1 strain elicits a potent CD8 ϩ T-cell-dependent lifelong protective immunity against infection with type I strains (13, 18) and against infection with type II strains and chronic infection (19) . In contrast, immunization with T. gondii extracts or killed noninvasive intact parasites does not elicit significant immunity to reinfection with T. gondii (2, 40) . Only actively infected host cells have been shown to prime CD8 ϩ T-cell-dependent immunity in T. gondii infection (10, 20, 21) .
Immunity is effectively elicited by immunization with the cps1-1 strain in C57BL/6 (18) , BALB/c (13) , and tyk2 Ϫ/Ϫ signaling-deficient mice (39) and surprisingly also in MyD88 Ϫ/Ϫ deficient mice (41) . Remarkably, macrophages primed in vivo by cps1-1 immunization but not naive macrophages also exhibit extremely efficient ex vivo IFN-␥-mediated innate cellular immunity augmenting intracellular rupture and clearance of type II and type III strains of T. gondii (30, (45) (46) (47) , whereas virulent type I strains resist this cps1-1-induced innate killing mechanism (46) .
The lifelong immunity elicited by vaccination with strain cps1-1 is dependent on CD8 ϩ T cells and interleukin 12 (IL-12) (41, 44) and is also dependent on IFN-␥ (13, 18), although systemic IFN-␥ is not required for priming (18) . Surprisingly, cps1-1 rapidly elicits functional IL-12p70 both locally and systemically following vaccination (18) . In contrast to current models of viral or intracellular bacterial infections, CD8
ϩ Tcell-intrinsic IL-12 signaling is required for development of IFN-␥-producing CD8 ϩ cytotoxic-T-lymphocyte populations and for the generation of memory CD8 ϩ T cells in response to cps1-1 (43, 44) . Vaccination with cps1-1 induced four distinct effector CD8
ϩ T-cell types based on KLRG1 and CD62L expression levels (44) . The rapidly elicited and abundant populations of antigen-specific effector CD8 ϩ T cells induced by vaccination with cps1-1 are cytolytic in vitro and in vivo (28) . The nonreplicating cps1-1 vaccine model has significantly advanced the understanding of the host response, innate immunity, and protective adaptive immunity to T. gondii infection (3, 10, 13, 18, 19, 28, 30, 39, 41, (43) (44) (45) (46) (47) .
The cps1-1 strain is not easily amenable to further genetic manipulation, and this strain exhibits an extremely low frequency of reversion to the virulent parental (strain RH) phenotype (13) . To further address the potential of the six-step pyrimidine synthesis pathway to develop improved avirulent, nonreverting, genetically defined, and genetically manipulatable strains, we deleted the sixth and final enzyme of the pathway by targeted disruption of the orotidine-5Ј-monophosphate (OMP) decarboxylase, the OMPDC gene, in the RH strain KU80 knockout background, which now enables highly efficient gene targeting (17, 24) . Targeted disruption of OMPDC via double-crossover homologous recombination induced severe pyrimidine auxotrophy and resulted in the generation of nonreverting strains that were essentially completely attenuated in their virulence in mice. A single immunization with ⌬OMPDC knockout strains effectively induced a potent protective immunity to subsequent lethal challenge infection with T. gondii.
MATERIALS AND METHODS
Primers. All oligonucleotide primers used in this study for targeting plasmid construction and PCR validation of knockout genotypes are given in Table S1 and Table S2 in the supplemental material.
Plasmid constructs. All plasmids were based on the yeast shuttle vector pRS416, which was employed in a yeast recombinational cloning system (33) . Briefly, recombination to fuse 3 distinct genetic elements (a 5Ј target flank, a hypoxanthine-xanthine-guanine phosphoribosyltransferase [HXGPRT] selectable marker, and a 3Ј target flank) in their correct order with pRS416 was performed using 31-to 34-bp crossovers common to pRS416, to the HXGPRT minicassette, or to gene targeting flanks (see Table S1 in the supplemental material) as required for yeast recombinational cloning (33) . The knockout targeting plasmids were engineered to delete a small amount of the gene's predicted 5Ј untranslated region (UTR) and essentially the entire predicted coding region of the targeted genomic locus. Targeting plasmids were verified by restriction enzyme digest and were then sequenced to verify 100% gene homology in targeting DNA flanks.
Plasmid pOMT2-2 was constructed to delete nucleotides 2715149 to 2718446 in the OMPDC locus, defined as TGGT1_010340 (55.m04842) on chromosome VIIb (chrVIIb) of the toxodb database (www.toxodb.org) (version 5.0). The HXGPRT minigene cassette (6, 7) was fused between a 1,055-bp 5Ј genomic targeting flank and a 994-bp 3Ј genomic targeting flank amplified from DNA isolated from the RH⌬ku80::HXGPRT strain (17) .
Plasmid pOMC2-4 was constructed to remove HXGPRT from the chromosomal locus of strain RH⌬ku80⌬ompdc::hxgprt (Table 1) . Plasmid pOMT2-2 was digested with PmeI to release the HXGPRT cassette fragment, followed by self-religation.
Plasmid pNUPT1-1 was designed to delete nucleotides 1108479 to 1111669 of the uridine phosphorylase (UP) locus on chrXI, annotated as TGGT1_086870. The HXGPRT minigene cassette was fused between a 1,024-bp 5Ј targeting fragment and a 934-bp3Ј targeting fragment.
Plasmid pGUPROMT was designed to complement uracil auxotrophy and disrupt UPRT. A chromosomal segment of 3,229 bp corresponding to nucleotides 2714788 to 2718017 on chrVIIb (the OMPDC gene) was flanked with a 1,131-bp 5Ј UPRT-targeting DNA flank and a 1,119-bp 3Ј UPRT-targeting DNA flank. Plasmid pGUPROMT was designed to replace nucleotides 2329098 to 2333188 of the annotated UPRT chromosomal locus, TGGT1_088770.
Strains, culture conditions, and plaque assays. The parental strains of T. gondii used in this study are RH (37) and the KU80 knockout strains RH⌬ku80::hxgprt and RH⌬ku80⌬hxgprt (17) . All strains used in this study are listed in Table 1 . Parasites were maintained by serial passage in diploid human foreskin fibroblasts (HFF) at 35°C (13) . PFU assays were performed over 7 days (36) unless otherwise stated. Uracil, uridine, cytidine, deoxyuridine, deoxycytidine, xanthine, mycophenolic acid (MPA), and 5-fluorodeoxyuridine (FUDR) were obtained from Sigma Inc., while 6-thioxanthine (6TX) was obtained from Acros Organics (Thermo Fisher Scientific).
Pyrimidine starvation viability assays. Pyrimidine auxotrophs were inoculated into two groups of 25-cm 2 HFF flasks, where one set of flasks was seeded with ϳ100 to 200 PFU (low dose) and the second set was seeded with ϳ1,000 to 2,000 PFU (high dose). Parasites were allowed to invade for 2 h in uracil medium and were then rinsed three times with cold phosphate-buffered saline (PBS) to remove uracil and extracellular parasites. Groups of three flasks from the lowdose and high-dose groups were then provided with uracil medium to establish the initial viability (day 0) measured by PFU assay without pyrimidine starvation. The remaining flasks were then incubated in medium lacking uracil to induce pyrimidine starvation. At different times (1, 3, or 5 days) after initiation of pyrimidine starvation, parasites in 3 flasks from the low-dose group and in 3 flasks from the high-dose group were rinsed with cold PBS and then provided with uracil medium to establish viability as measured by PFU assay. The percentage of initial viability remaining after different times of pyrimidine starvation was determined from PFU counts. PFU data were subjected to a Student t test and are represented as the means Ϯ the standard errors of the means (SEM).
Genomic DNA isolation and PCR. Genomic DNA was purified using a DNA blood minikit (Qiagen). PCR products were amplified using a 1:1 mixture of Taq DNA polymerase and Expand Long template PCR (Roche). 
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Transformation of Toxoplasma gondii and knockout verification strategy. Electroporations were performed on the model BTX600 electroporator with 1.33 ϫ 10 7 freshly isolated tachyzoites in the presence of ϳ15 g of linearized targeting plasmid DNA as described previously (17) . Following selection of parasite clones, the genotypes of clones were validated in PCR assays to measure the following: (i) PCR 1, loss of the deleted coding region of the targeted gene (DF and DR primers); (ii) PCR 2, presence of a target DNA flank (CXF and EXR primers); (iii) PCR 3, correct targeted 5Ј integration (CXF and 5ЈDHFRCXR primers); and (iv) PCR 4, correct targeted 3Ј integration (3ЈDHFRCXF and CXR primers) using a previously described strategy (17) .
Single and double knockouts at the OMPDC (⌬ompdc) and UP (⌬up) loci. The RH⌬ku80⌬hxgprt strain was transfected with SpeI-linearized pOMT2-2 or with SpeI-linearized pNUPT1-1, and knockouts were continuously selected in MPA (25 g/ml), xanthine (250 M), and uracil (250 M) to isolate the cloned strains RH⌬ku80⌬ompdc::hxgprt and RH⌬ku80⌬up::hxgprt, respectively. To remove the HXGPRT minigene cassette from the RH⌬ku80⌬ompdc::hxgprt strain, parasites were transfected with SpeI-linearized pOMC2-4 and selected in 6TX (250 g/ml) and uracil (250 M). Strain RH⌬ku80⌬ompdc⌬hxgprt was validated using PCR 5 with a forward primer (CLOMF) designed in the 3Ј side of the 5Ј targeting flank and the CXR primer. The strain was transfected with SpeIlinearized pNUPT1-1, and the strain RH⌬ku80⌬ompdc⌬up::hxgprt was selected in MPA, xanthine, and uracil medium.
Functional complementation of strain RH⌬ku80⌬ompdc::hxgprt. Strain RH⌬ku80⌬ompdc::hxgprt was transfected with the PmeI-linearized plasmid pGUPROMT, containing the 3,229-bp OMPDC locus. Following transfection, the culture was maintained in the presence of uracil (250 M) for 24 h, uracil medium was removed, and the selection was then continued in the absence of uracil. Parasites emerging from this selection were subcloned, and individual isolates were evaluated for their genotype to verify targeted deletion of UPRT and the simultaneous insertion of a functional allele of OMPDC. The genotype of the expected gene replacement at the UPRT locus was verified in PCR 1 to assay for deletion of UPRT, in PCR 6 to assay for correct integration of the genomic allele of OMPDC (using the primers UPRTCXF and OMXEXR), and by verifying that individual clonal isolates were also uniformly resistant to 5 M FUDR to demonstrate a functional loss of UPRT.
Virulence assays, immunizations, and challenge infections. Adult 6-to 8-week-old C57BL/6 mice and gamma interferon␥ knockout mice, B6.129S7-Ifng ) were injected intraperitoneally (i.p.) with 0.2 ml PBS containing defined numbers of tachyzoites, and mice were then monitored daily for degree of illness and survival. Virulence assays were performed twice. C57BL/6 mice that survived the virulence assay challenge infections were used in subsequent experiments to determine whether mice were immune to lethal challenge infections. Surviving immunized mice were infected i.p. with 200 tachyzoites (LD200) of strain RH 1 month after immunization along with age-matched naive mouse controls, and mice were then monitored daily to determine the degree of illness and survival.
RESULTS
Genetic dissection of pyrimidine synthesis and salvage in T. gondii. To further define the functional role of the de novo pyrimidine synthesis pathway, we targeted the last step of the pathway encoded by the OMPDC gene (Fig. 1) . Targeting OMPDC eliminates the possibility that the parasite can access and salvage any host cell intermediates in the pyrimidine synthesis pathway prior to OMP (Fig. 1) . The host cell nucleotides OMP, UMP, and TMP are inaccessible to the parasite via any direct salvage pathway (4, 14) . We also targeted the UP activity to functionally address the potential of the pyrimidine salvage pathway to compensate for defects in the biosynthetic pathway (Fig. 1) . Targeting UP in the salvage pathway eliminates direct access to host pyrimidine nucleosides (uridine, cytidine, deoxyuridine, and deoxycytidine) that can be transported into the parasite (5). Consequently, phenotypic evaluation of single knockouts at the OMPDC and UP loci in conjunction with evaluation of a double knockout (OMPDC and UP) was predicted to provide a valid test of the current model for pyrimidine synthesis and salvage in T. gondii ( Fig. 1) (14) .
Targeted deletions were constructed in the OMPDC gene using a strategy ( Fig. 2A) based on efficient gene targeting via double-crossover homologous recombination in strain RH⌬ku80⌬hxgprt (17) . The same strategy illustrated in Fig. 2A was also used to create a targeted disruption of the UP gene. The disrupted UP strain (RH⌬ku80⌬ompdc::HXGPRT) exhibited an intracellular growth rate and plaque forming ability identical to that of the parental strain, RH⌬ku80::HXGPRT (data not shown). Cloned isolates of the ⌬OMPDC (strain RH⌬ku80⌬ompdc::HXGPRT) and ⌬UP (strain RH⌬ku80⌬up::HXGPRT) knockouts were verified genotypically using a PCR strategy to demonstrate precisely targeted deletion and insertion of the selectable marker HXG-PRT at the targeted loci (Fig. 1) , (see Materials and Methods; also data not shown). The ⌬OMPDC knockout was then retargeted at the disrupted OMPDC locus using the plasmid pOMC2-2, which, while retaining the same 5Ј and 3Ј target flanks, was deleted for the HXGPRT marker. Transfected ⌬OMPDC knockouts were selected in 6TX to select for tar- (Fig. 2B) . Clones resistant to 6TX were isolated, and the genotype of the ⌬OMPDC strain deleted for HXGPRT (strain RH⌬ku80⌬ompdc⌬hxgprt) was confirmed by PCR genotyping (data not shown). The ⌬OMPDC strain deleted for HXG-PRT was then retargeted using the UP deletion targeting plasmid pNUPT1-1 to generate the double knockout ⌬OMPDC ⌬UP strain (strain RH⌬ku80⌬ompdc⌬up::HXGPRT) ( Table 1 ). The ⌬OMPDC and ⌬OMPDC ⌬UP strains were also evaluated for their reversion frequency using PFU assays performed in the absence of uracil supplementation. As expected, no revertants were detected in multiple independent PFU assays using a total of ϳ1 ϫ 10 9 tachyzoites of the ⌬OMPDC or ⌬OMPDC ⌬UP strain (data not shown).
Functional analysis of pyrimidine synthesis and salvage potential in T. gondii. The precisely targeted and deleted ⌬OMPDC, ⌬UP, and ⌬OMPDC ⌬UP strains were examined for growth in the absence of uracil supplementation in PFU assays to illustrate the growth phenotypes. The ⌬UP strain and the parental KU80 knockout strains replicate normally in the absence and presence of uracil, uridine, or cytidine (data not shown). In contrast, while the growth rates of the ⌬OMPDC and ⌬OMPDC ⌬UP strains were normal in uracil, both strains exhibited a severe pyrimidine auxotrophy and replication deficiency in the absence of uracil supplementation (Fig. 3A and  B) . In contrast to the complete rescue of growth and PFU observed with uracil supplementation, replication of the ⌬OMPDC strain was only partially rescued with high concentrations of uridine and was poorly rescued with high concentrations of cytidine, as revealed by the markedly decreasing sizes of the zones of infection present in the PFU (Fig. 3C) . Similar rescue profiles were also observed using deoxyuridine or deoxycytidine, respectively (data not shown). This pyrimidine rescue profile suggested a differential flux of metabolites depending on their point of entry into the salvage pathway ( Fig. 1) . Collectively, these results demonstrated that in the ⌬OMPDC background, the parasite-encoded UP provided at least partial functional rescue of parasite growth of pyrimidine auxotrophs in vitro through conversion of uridine to uracil or minor rescue through cytidine that was first converted to uridine by a cytidine deaminase (CTD) activity if extremely high concentrations of uridine or cytidine, respectively, were exogenously supplied in culture medium (Fig. 1 ).
To definitively demonstrate that the parasite UP acted in the salvage pathway depicted in Fig. 1 rather than via any potential alternative pathway to partially rescue pyrimidine auxotrophy in vitro, we examined the double knockout ⌬OMPDC ⌬UP strain in the same PFU rescue assays (Fig. 3D) . Growth rescue was not observed in the ⌬OMPDC ⌬UP strain using either 200 M uridine or 200 M cytidine supplementation or by supplementing medium with 4 mM concentrations of uridine or cytidine (data not shown). Replication of the ⌬OMPDC ⌬UP strain could be rescued only by uracil supplementation in vitro (Fig. 3B) .
Complementation of pyrimidine auxotrophy. Genotyping of the ⌬OMPDC, ⌬UP, and ⌬OMPDC ⌬UP knockout strains indicated precise disruption of the targeted loci in the KU80 knockout background. To demonstrate that the knockout strains had precisely targeted deletions with no unknown pleiotropic or epigenetic alterations that could potentially influence the phenotype(s) under observation, we functionally complemented the pyrimidine auxotrophy. A functional wild-type allele of the OMPDC gene was inserted by targeted gene replacement into the UPRT locus, simultaneously deleting the coding region of the UPRT gene (Fig. 4A) . Since the rescue of pyrimidine auxotrophy in T. gondii is completely dependent on UPRT ( Fig. 1) (14) , selection of targeted ⌬OMPDC strains is feasible in the absence of uracil only if functional complementation is successful. The complemented ⌬OMPDC strain RH⌬ku80⌬ompdc::HXGPRT⌬uprt::gOMPDC (Table 1) was disrupted in UPRT and was resistant to FUDR, and the growth rate of the complemented strain was normal whether uracil was absent or present in culture medium (Fig. 4B) .
Pyrimidine starvation causes a rapid loss of viability. PFU assays were used to measure how rapidly pyrimidine auxotrophs lost viability intracellularly under conditions of pyrimidine starvation. When subjected to pyrimidine starvation, the ⌬OMPDC ⌬UP knockout strain lost viability at a markedly higher rate than the ⌬OMPDC knockout strain (Fig. 5) . A significant loss in viability of the ⌬OMPDC ⌬UP knockout was detected as early as 1 day after initiation of pyrimidine starvation. After 5 days of pyrimidine starvation, the viability of the ⌬OMPDC ⌬UP knockout strain was reduced to 1.1% Ϯ 0.6% of the initial viability, whereas that of the ⌬OMPDC knockout strain was reduced to 38% Ϯ 1.8% of the initial viability (Fig. 5) .
Pyrimidine biosynthesis is required for virulence. The attenuation of virulence of the nonreverting ⌬OMPDC, ⌬UP, and ⌬OMPDC ⌬UP knockout strains was evaluated. C57BL/6 mice inoculated intraperitoneally (i.p.) with a dose of 20 tachyzoites of the parental strain RH⌬ku80::HXGPRT or with a dose of 20 tachyzoites of the ⌬UP strain uniformly succumbed to virulent infection (Fig. 6A) . In contrast, C57BL/6 mice inoculated i.p. with a dose of 1 ϫ 10 6 , 1 ϫ 10 7 , or 5 ϫ 10 7 tachyzoites of either the ⌬OMPDC strain or the ⌬OMPDC ⌬UP strain uniformly survived each of these extremely highdose parasite challenges ( ⌬UP tachyzoites (Fig. 6B) . Significantly, extreme virulence was restored in the complemented uracil auxotroph strain RH⌬ku80⌬ompdc::HXGPRT⌬uprt::gOMPDC (Fig. 6C) .
⌬OMPDC and ⌬OMPDC ⌬UP strains elicit protective immunity against virulent T. gondii infection. To examine the potential of the ⌬OMPDC and ⌬OMPDC ⌬UP strains to serve as vaccines, C57BL/6 mice that survived the initial challenge infections with these strains were rechallenged 30 days later with 200 tachyzoites of strain RH (LD200). All mice vaccinated with a single dose of 1 ϫ 10 6 , 1 ϫ 10 7 , or 5 ϫ 10 7 tachyzoites of the ⌬OMPDC strain or the ⌬OMPDC ⌬UP strain uniformly survived lethal RH challenge infection (Fig.  6D) . In contrast, all naive C57BL/6 mice rapidly succumbed to the lethal RH challenge infection.
DISCUSSION
Insertional disruption of the first step of the de novo pyrimidine synthesis pathway, encoded by the CPSII gene, produced severe uracil auxotrophic mutants of T. gondii that were incapable of de novo pyrimidine synthesis (13) (14) (15) (16) . After invasion of a host cell, the cps1-1 uracil auxotrophic mutant was starved for pyrimidines and did not replicate. However, the cps1-1 strain is not easily amenable to further genetic manipulation, and the disruption in CPSII in this strain is insertional rather than deletional (13) . To develop improved nonreverting, avirulent, and well-defined strains that are more easily amenable to additional defined genetic manipulations, we utilized recently developed KU80 knockout strains (17) to precisely target and delete the gene encoding the final step of the pyrimidine biosynthetic pathway, the OMPDC activity. We also examined the functional capacity of the pyrimidine salvage pathways by deleting the UP salvage activity, which controls the direct access to host cell pyrimidine nucleosides (26) , with or without an intact pyrimidine biosynthetic pathway. The parasite UP activity is nonspecific and is active on uridine, deoxyuridine, and thymidine (26) .
As predicted from the current model for T. gondii pyrimidine pathways (Fig. 1) , disruption of the UP activity had no effect on parasite growth or virulence. In contrast, disruption of OMPDC in the ⌬OMPDC strain produced a severe uracil auxotrophy due to the loss of UMP derived from the de novo pyrimidine synthesis pathway. Rescue of the UMP pool from the salvage pathway minimally requires parasite UPRT and pyrimidine supplementation to the growth medium. The nucleobase uracil provided the most effective functional rescue of the UMP pool, and uracil supplementation restored a normal growth rate in the ⌬OMPDC strain. The replication of the ⌬OMPDC strain was also partially rescued with high concen- trations of uridine and was detectably but poorly rescued with high concentrations of cytidine. This pyrimidine rescue profile suggested a differential flux of metabolites depending on their point of entry into the salvage pathway. Since cytidine must be first converted to uridine by a CTD activity, this nucleoside provides reduced rescue compared to that of uridine, and also, uridine provided reduced rescue compared to that of uracil. Similar rescue results were observed for deoxyuridine and deoxycytidine, respectively, consistent with previous evidence showing the parasite UP and CTD activities are active on both the ribonucleoside and the deoxyribonucleoside (11, 25) .
T. gondii has no detectable pyrimidine nucleoside kinase activity (26) , and cleavage of nucleosides is due to nucleoside phosphorylase activities rather than any prominent nucleoside hydrolase activity (25) . Additionally, no detectable pathway to transport or directly salvage host cell pyrimidine nucleotides exists (5, 14) . Consequently, we conclude that the potential salvage of host cell uracil and nucleosides (cytidine, deoxycytidine, uridine, and deoxyuridine) is not sufficient to support a significant rate of parasite replication in mammalian cells in vitro in pyrimidine auxotroph backgrounds created by disruption of the OMPDC activity in the biosynthetic pathway.
Our study did not define whether the CTD that converts cytidine to uridine is a host cell-encoded enzyme or a parasiteencoded enzyme. The genome of T. gondii predicts a putative gene locus for a potential CTD gene (TGGT1_051230), and as mentioned, a CTD activity has been previously found in isolated tachyzoites (25) . However, because the enzyme activity originally reported for the CTD was very low (25) , the possibility of host cell contamination of the enzyme preparations cannot be completely discounted and a genetic approach is still necessary to conclusively address the functional origin of the CTD that partially rescues growth of the ⌬OMPDC pyrimidine auxotroph in this study. Rescue of pyrimidine auxotrophy using exogenously supplied uracil or pyrimidine nucleosides minimally also mechanistically requires parasite plasma membrane transporters for these pyrimidines, and nucleobase and nucleoside transporters have been found in T. gondii (5) . Our study also did not address whether host cell transporters are necessary for salvage of exogenously supplied pyrimidines.
While growth of the ⌬OMPDC ⌬UP strain was also rescued completely by uracil supplementation, replication of this double knockout was not rescued by supplementation of growth medium with either uridine or cytidine or their corresponding deoxyribonucleosides. These results definitively demonstrate that the salvage of all host cell-derived pyrimidine nucleosides (cytidine, deoxycytidine, uridine, and deoxyuridine) into the UMP pool of the parasite is dependent on the sequential action of the parasite-encoded UP and UPRT activities. These results suggest that the infected host cell UP activity does not play any significant role in supporting parasite replication by providing uracil to the pyrimidine salvage pathway of the intracellular parasite. However, our experiments do not exclude the possibility that the parasite has limited access to host cell uracil made available through the activity of the host cellencoded UP, but if so, the biochemical flux of this pathway is not sufficient to support parasite replication.
Previous biochemical and genetic results implicated a potentially significant role of the parasite-specific pathway in salvage of pyrimidines (4, 13, 14, 25, 35) , although it has still been poorly understood how the biosynthetic and salvage pathways are integrated and regulated. The ability to now more rapidly and reliably target gene knockouts and gene replacements in the KU80 knockout background should accelerate progress in understanding the pyrimidine pathways, as well as essential purine salvage and other nutritional pathways critical to intracellular parasite survival and growth (17) . Simultaneous complementation of pyrimidine auxotrophy and targeted disruption of UPRT (⌬UPRT) with a functional allele of OMPDC in the ⌬OMPDC background now conclusively demonstrate that T. gondii can grow normally with UMP derived from a fully functional de novo pyrimidine synthesis pathway while having no functional pyrimidine salvage pathway. Conversely, if a ⌬OMPDC or ⌬OMPDC⌬UP pyrimidine auxotroph strain is provided with high levels of the pyrimidine supplement uracil in growth medium in vitro, the parasite can also grow normally while deriving UMP from the pyrimidine salvage pathway in the absence of any functional biosynthetic pathway.
The absence of UP has no apparent effect on parasite growth or virulence. However, our assays of viability following pyrimidine starvation demonstrate that the presence or absence of UP in pyrimidine auxotrophs is correlated with viability. After 5 days of pyrimidine starvation, the ⌬OMPDC knockout strain retained 38% Ϯ 1.8% viability while the ⌬OMPDC ⌬UP double knockout strain retained only 1.1% Ϯ 0.6% viability. Our previous kinetic analysis of pyrimidine starvation showed that after 5 days of pyrimidine starvation, the cps1-1 strain retained ϳ25% viability (13) . Collectively, these observations suggest that the loss of viability of ⌬OMPDC knockouts during pyrimidine starvation is significantly accelerated in the absence of the parasite UP activity.
The essential nature of de novo pyrimidine synthesis, the extremely limited functional capacities of the pyrimidine salvage pathway in infected host cells in the absence of pyrimidine supplementation in vitro, and evidence suggesting that uracil is not readily available in mammals (12, 13, 32) collectively explain the remarkable attenuation of growth in vitro and attenuation of virulence in mice that we observed in the ⌬OMPDC and ⌬OMPDC ⌬UP strains. The attenuation in virulence of these nonreverting pyrimidine auxotroph strains approaches ϳ8 logs (or more) compared to the virulent parent RH strain, where a single viable parasite is lethal to mice (36) . The ⌬OMPDC ⌬UP strain also exhibits extreme attenuation in IFN-␥ Ϫ/Ϫ mice, suggesting that the growth disruption in this background is severe in vivo. Uracil auxotrophy is a profoundly effective strategy to eliminate virulence in T. gondii infection.
A single immunization of mice with the ⌬OMPDC strain or the ⌬OMPDC ⌬UP strain elicited a completely protective immunity to lethal challenge infection. The cps1-1 strain elicits a potent CD8 ϩ T-cell-dependent protective immunity (13, 18, 19, 28, 39, 41) that confers lifelong immunity against infection with type I strains (13, 18) , as well as lifelong immunity against infection with type II strains and chronic infection (19) . The cps1-1-induced immunity is dependent on IL-12 (18, 41, 44) and is also dependent on IFN-␥ (13, 18), although systemic IFN-␥ is not required for priming this immunity (18) . This priming of immunity is characterized by four distinct effector CD8 ϩ T-cell types based on KLRG1 and CD62L expression levels (44) that produce abundant populations of antigen-spe-cific CD8 ϩ T cells that are cytolytic in vitro and in vivo (28) and also elicits effective generation of memory CD8 ϩ T cells (43, 44) . Recently the CD8 ϩ T-cell-dependent immunity elicited by the attenuated cps1-1 uracil auxotroph strain, which actively invades the host cell but does not subsequently replicate, was reported to arise unexpectedly with much faster kinetics than that observed with replicating strains that actively lyse the infected cell (28) . Surprisingly, the early cytokine response to the type I uracil auxotroph strain cps1-1 also resembles the characteristic response of a type II strain in regard to early production of IL-12 (18) . RH challenge parasites are not detected in cps1-1-vaccinated mice by ϳ3 weeks after challenge, and the genomes of tachyzoites from the original cps1-1 vaccination also are not detected at the same time the RH challenge parasites are assayed (18, 28) . While the ⌬OMPDC and ⌬OMPDC ⌬UP strains elicit an effective protective immune response against lethal RH challenge, additional experiments are needed to determine whether long-term immunity is elicited and whether these new strains can be further manipulated to elicit a protective antigen-based response against other pathogens in naive mice or in mice already immune to T. gondii.
Our study provides further evidence that the de novo pyrimidine synthesis pathway of T. gondii is essential and that this pathway provides an excellent target for vaccine design and chemotherapy. This study defines and validates potentially improved, extremely attenuated, nonreverting, genetically defined, and now genetically manipulatable strains developed in the KU80 knockout background that enable precise and efficient gene targeting via homologous recombination (17) . The ⌬OMPDC and ⌬OMPDC ⌬UP strains developed in this study should also provide new tools for the further biological dissection of innate and adaptive host responses to T. gondii infection. Significantly, the newly developed nonreverting avirulent uracil auxotroph strains reported here now potentially provide an excellent vaccine platform strategy in which to examine engineered antigens or CD8 ϩ T-cell epitopes of interest that can elicit potent Th1 and other relevant immune responses to combat significant global infectious diseases that have been remarkably resistant to previous vaccination strategies.
